nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.547	0.691	CbGbCtD
Azelastine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.244	0.309	CbGbCtD
Azelastine—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0747	CcSEcCtD
Azelastine—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0098	0.053	CcSEcCtD
Azelastine—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00849	0.046	CcSEcCtD
Azelastine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00594	0.0321	CcSEcCtD
Azelastine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00578	0.0313	CcSEcCtD
Azelastine—Mazindol—SIGMAR1—amyotrophic lateral sclerosis	0.00517	1	CrCbGaD
Azelastine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0278	CcSEcCtD
Azelastine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0258	CcSEcCtD
Azelastine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0257	CcSEcCtD
Azelastine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0246	CcSEcCtD
Azelastine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0245	CcSEcCtD
Azelastine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0238	CcSEcCtD
Azelastine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0223	CcSEcCtD
Azelastine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0196	CcSEcCtD
Azelastine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0182	CcSEcCtD
Azelastine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0174	CcSEcCtD
Azelastine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0173	CcSEcCtD
Azelastine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00312	0.0169	CcSEcCtD
Azelastine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0168	CcSEcCtD
Azelastine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00292	0.0158	CcSEcCtD
Azelastine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0156	CcSEcCtD
Azelastine—HRH3—hindbrain—amyotrophic lateral sclerosis	0.00287	0.171	CbGeAlD
Azelastine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0144	CcSEcCtD
Azelastine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0141	CcSEcCtD
Azelastine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00251	0.0136	CcSEcCtD
Azelastine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00241	0.0131	CcSEcCtD
Azelastine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0129	CcSEcCtD
Azelastine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00222	0.012	CcSEcCtD
Azelastine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0119	CcSEcCtD
Azelastine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0118	CcSEcCtD
Azelastine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0114	CcSEcCtD
Azelastine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0113	CcSEcCtD
Azelastine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0112	CcSEcCtD
Azelastine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0106	CcSEcCtD
Azelastine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00967	CcSEcCtD
Azelastine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00965	CcSEcCtD
Azelastine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00957	CcSEcCtD
Azelastine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00953	CcSEcCtD
Azelastine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00914	CcSEcCtD
Azelastine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00906	CcSEcCtD
Azelastine—HRH3—brainstem—amyotrophic lateral sclerosis	0.00165	0.0982	CbGeAlD
Azelastine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00889	CcSEcCtD
Azelastine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00885	CcSEcCtD
Azelastine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00871	CcSEcCtD
Azelastine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0086	CcSEcCtD
Azelastine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00851	CcSEcCtD
Azelastine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00839	CcSEcCtD
Azelastine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00839	CcSEcCtD
Azelastine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00836	CcSEcCtD
Azelastine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00829	CcSEcCtD
Azelastine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00821	CcSEcCtD
Azelastine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00811	CcSEcCtD
Azelastine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00804	CcSEcCtD
Azelastine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00799	CcSEcCtD
Azelastine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00785	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00733	CcSEcCtD
Azelastine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00722	CcSEcCtD
Azelastine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00717	CcSEcCtD
Azelastine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00715	CcSEcCtD
Azelastine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00693	CcSEcCtD
Azelastine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00688	CcSEcCtD
Azelastine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00688	CcSEcCtD
Azelastine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00663	CcSEcCtD
Azelastine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00658	CcSEcCtD
Azelastine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00636	CcSEcCtD
Azelastine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00636	CcSEcCtD
Azelastine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00593	CcSEcCtD
Azelastine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00577	CcSEcCtD
Azelastine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00569	CcSEcCtD
Azelastine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0055	CcSEcCtD
Azelastine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000983	0.00532	CcSEcCtD
Azelastine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00511	CcSEcCtD
Azelastine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000937	0.00507	CcSEcCtD
Azelastine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000936	0.00507	CcSEcCtD
Azelastine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000931	0.00504	CcSEcCtD
Azelastine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00478	CcSEcCtD
Azelastine—HRH3—nervous system—amyotrophic lateral sclerosis	0.000863	0.0514	CbGeAlD
Azelastine—HRH3—central nervous system—amyotrophic lateral sclerosis	0.000831	0.0495	CbGeAlD
Azelastine—HRH3—cerebellum—amyotrophic lateral sclerosis	0.000812	0.0484	CbGeAlD
Azelastine—HRH3—brain—amyotrophic lateral sclerosis	0.00066	0.0393	CbGeAlD
Azelastine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000507	0.0302	CbGeAlD
Azelastine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00046	0.0274	CbGeAlD
Azelastine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.000443	0.0264	CbGeAlD
Azelastine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000383	0.0228	CbGeAlD
Azelastine—ADRA1B—brain—amyotrophic lateral sclerosis	0.000351	0.0209	CbGeAlD
Azelastine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.000332	0.0198	CbGeAlD
Azelastine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000311	0.0185	CbGeAlD
Azelastine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000296	0.0176	CbGeAlD
Azelastine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00029	0.0173	CbGeAlD
Azelastine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000256	0.0152	CbGeAlD
Azelastine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000249	0.0149	CbGeAlD
Azelastine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.00024	0.0143	CbGeAlD
Azelastine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000235	0.014	CbGeAlD
Azelastine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000228	0.0136	CbGeAlD
Azelastine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000228	0.0136	CbGeAlD
Azelastine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000211	0.0125	CbGeAlD
Azelastine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000205	0.0122	CbGeAlD
Azelastine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000203	0.0121	CbGeAlD
Azelastine—HRH1—nervous system—amyotrophic lateral sclerosis	0.0002	0.0119	CbGeAlD
Azelastine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000197	0.0117	CbGeAlD
Azelastine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000192	0.0115	CbGeAlD
Azelastine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000192	0.0114	CbGeAlD
Azelastine—KCNH2—brain—amyotrophic lateral sclerosis	0.000191	0.0114	CbGeAlD
Azelastine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000185	0.011	CbGeAlD
Azelastine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000181	0.0108	CbGeAlD
Azelastine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000174	0.0104	CbGeAlD
Azelastine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000161	0.00959	CbGeAlD
Azelastine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000156	0.00932	CbGeAlD
Azelastine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000155	0.00921	CbGeAlD
Azelastine—HRH1—brain—amyotrophic lateral sclerosis	0.000153	0.0091	CbGeAlD
Azelastine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000152	0.00906	CbGeAlD
Azelastine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000149	0.00887	CbGeAlD
Azelastine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000147	0.00875	CbGeAlD
Azelastine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000146	0.00872	CbGeAlD
Azelastine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000146	0.00867	CbGeAlD
Azelastine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000143	0.00853	CbGeAlD
Azelastine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00013	0.00774	CbGeAlD
Azelastine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000116	0.00693	CbGeAlD
Azelastine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000109	0.00652	CbGeAlD
Azelastine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000105	0.00628	CbGeAlD
Azelastine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000103	0.00613	CbGeAlD
Azelastine—ABCB1—brain—amyotrophic lateral sclerosis	8.36e-05	0.00498	CbGeAlD
Azelastine—HRH3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.7e-06	0.00158	CbGpPWpGaD
Azelastine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.69e-06	0.00158	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.67e-06	0.00157	CbGpPWpGaD
Azelastine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.66e-06	0.00156	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	3.65e-06	0.00156	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.65e-06	0.00156	CbGpPWpGaD
Azelastine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.64e-06	0.00156	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.64e-06	0.00155	CbGpPWpGaD
Azelastine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.61e-06	0.00154	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.51e-06	0.0015	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.5e-06	0.0015	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.47e-06	0.00148	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.46e-06	0.00148	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.45e-06	0.00148	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.45e-06	0.00147	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.45e-06	0.00147	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.45e-06	0.00147	CbGpPWpGaD
Azelastine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.44e-06	0.00147	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.44e-06	0.00147	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.44e-06	0.00147	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.4e-06	0.00145	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.39e-06	0.00145	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.38e-06	0.00145	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.31e-06	0.00141	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.25e-06	0.00139	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.22e-06	0.00138	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.21e-06	0.00137	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.2e-06	0.00137	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.19e-06	0.00136	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	3.18e-06	0.00136	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.15e-06	0.00135	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.13e-06	0.00134	CbGpPWpGaD
Azelastine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.13e-06	0.00134	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.13e-06	0.00134	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.09e-06	0.00132	CbGpPWpGaD
Azelastine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.08e-06	0.00132	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.08e-06	0.00132	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.08e-06	0.00131	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.08e-06	0.00131	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.07e-06	0.00131	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3e-06	0.00128	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3e-06	0.00128	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3e-06	0.00128	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.98e-06	0.00127	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.95e-06	0.00126	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.94e-06	0.00126	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.93e-06	0.00125	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.88e-06	0.00123	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.88e-06	0.00123	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.87e-06	0.00123	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.83e-06	0.00121	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.83e-06	0.00121	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.81e-06	0.0012	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.8e-06	0.0012	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.8e-06	0.0012	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	2.8e-06	0.0012	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.76e-06	0.00118	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.75e-06	0.00118	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.75e-06	0.00117	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.72e-06	0.00116	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.66e-06	0.00114	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.66e-06	0.00114	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.63e-06	0.00112	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.63e-06	0.00112	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.62e-06	0.00112	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.61e-06	0.00112	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.59e-06	0.00111	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.56e-06	0.0011	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.55e-06	0.00109	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	2.55e-06	0.00109	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.49e-06	0.00106	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.47e-06	0.00106	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.46e-06	0.00105	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.41e-06	0.00103	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.41e-06	0.00103	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.41e-06	0.00103	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.4e-06	0.00103	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.4e-06	0.00102	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.4e-06	0.00102	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.38e-06	0.00102	CbGpPWpGaD
Azelastine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.38e-06	0.00102	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.38e-06	0.00102	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.37e-06	0.00101	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.27e-06	0.000968	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.26e-06	0.000966	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.25e-06	0.000962	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.24e-06	0.000958	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.23e-06	0.000955	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.23e-06	0.000953	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.22e-06	0.00095	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.19e-06	0.000937	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.18e-06	0.000933	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.18e-06	0.000933	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.18e-06	0.000932	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	2.18e-06	0.000931	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.17e-06	0.000927	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.15e-06	0.000918	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.09e-06	0.000895	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.08e-06	0.000889	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.06e-06	0.00088	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.06e-06	0.000879	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.05e-06	0.000876	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.05e-06	0.000874	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.04e-06	0.000871	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.03e-06	0.000869	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.03e-06	0.000866	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	2.02e-06	0.000861	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	2.01e-06	0.00086	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.94e-06	0.000831	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.92e-06	0.000819	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.9e-06	0.000812	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.89e-06	0.000807	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.88e-06	0.000805	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.87e-06	0.000798	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.85e-06	0.00079	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.85e-06	0.00079	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.85e-06	0.000789	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.83e-06	0.00078	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.74e-06	0.000745	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.73e-06	0.00074	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.73e-06	0.00074	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.73e-06	0.00074	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.69e-06	0.000723	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.69e-06	0.000722	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.69e-06	0.00072	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.68e-06	0.000718	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.67e-06	0.000714	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.66e-06	0.000707	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.65e-06	0.000706	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.65e-06	0.000706	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.64e-06	0.000703	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.59e-06	0.000678	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.57e-06	0.000672	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.56e-06	0.000667	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.56e-06	0.000665	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-06	0.000662	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.54e-06	0.000657	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.53e-06	0.000653	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.52e-06	0.000649	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.49e-06	0.000635	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.48e-06	0.000632	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.47e-06	0.000628	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.43e-06	0.000611	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-06	0.000611	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.42e-06	0.000609	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.42e-06	0.000606	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.42e-06	0.000605	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.38e-06	0.000591	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.35e-06	0.000577	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.35e-06	0.000575	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.34e-06	0.000571	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.31e-06	0.000561	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.31e-06	0.000558	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.29e-06	0.000553	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.29e-06	0.000552	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.28e-06	0.000546	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.25e-06	0.000536	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.25e-06	0.000533	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.22e-06	0.000522	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.22e-06	0.000522	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.21e-06	0.000518	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.18e-06	0.000503	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-06	0.000502	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.17e-06	0.000498	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.16e-06	0.000498	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.14e-06	0.000485	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-06	0.000481	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.12e-06	0.000479	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.11e-06	0.000475	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.1e-06	0.000472	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.1e-06	0.000469	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.07e-06	0.000455	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.06e-06	0.000454	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.03e-06	0.000442	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.01e-06	0.000434	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.01e-06	0.000433	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.95e-07	0.000425	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.76e-07	0.000417	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.59e-07	0.00041	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.35e-07	0.0004	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.08e-07	0.000388	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.08e-07	0.000388	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.02e-07	0.000385	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.95e-07	0.000382	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.9e-07	0.00038	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.88e-07	0.000379	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.68e-07	0.000371	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	8.51e-07	0.000364	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.39e-07	0.000358	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.35e-07	0.000357	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.29e-07	0.000354	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.18e-07	0.000349	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.17e-07	0.000349	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.16e-07	0.000349	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.98e-07	0.000341	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.97e-07	0.000341	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.71e-07	0.000329	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.69e-07	0.000329	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.68e-07	0.000328	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.42e-07	0.000317	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.28e-07	0.000311	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.22e-07	0.000308	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.07e-07	0.000302	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	6.87e-07	0.000293	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.86e-07	0.000293	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	6.73e-07	0.000287	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.72e-07	0.000287	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.71e-07	0.000287	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.7e-07	0.000286	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.34e-07	0.000271	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.31e-07	0.00027	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.31e-07	0.00027	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.26e-07	0.000267	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.22e-07	0.000266	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.16e-07	0.000263	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.13e-07	0.000262	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.83e-07	0.000249	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.81e-07	0.000248	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.8e-07	0.000248	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.75e-07	0.000246	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.55e-07	0.000237	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.35e-07	0.000229	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	5.19e-07	0.000222	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.07e-07	0.000216	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.91e-07	0.00021	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.77e-07	0.000204	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.73e-07	0.000202	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.72e-07	0.000202	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.71e-07	0.000201	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.61e-07	0.000197	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.6e-07	0.000197	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.46e-07	0.000191	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.35e-07	0.000186	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.27e-07	0.000183	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.13e-07	0.000176	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.04e-07	0.000173	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.04e-07	0.000173	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.01e-07	0.000171	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.98e-07	0.00017	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.79e-07	0.000162	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.63e-07	0.000155	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.56e-07	0.000152	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.47e-07	0.000148	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.27e-07	0.00014	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.24e-07	0.000139	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.12e-07	0.000133	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.03e-07	0.000129	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.77e-07	0.000118	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.74e-07	0.000117	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.14e-07	9.14e-05	CbGpPWpGaD
